Contractile function in hypertrophied myocardium

January 1997
Age & Ageing;Jan97 Supplement, Vol. 26, p4
Academic Journal
Presents an abstract of the study `Contractile Function in Hypertrophied Myocardium,' by R. Gray, H. McIntyre et al, presented during the communications to the autumn meeting of the British Geriatrics Society on October 3-4, 1996 in London, England.


Related Articles

  • Hypertrophic cardiomyopathy/ Pathophysiology, diagnosis and treatment. Popjes, Eric D.; Sutton, Martin St. John // Geriatrics;Mar2003, Vol. 58 Issue 3, p41 

    Discusses the pathophysiology, diagnosis and treatment of hypertrophic cardiomyopathy (HCM). Characteristics of HCM; Natural history; Genetic aspects; Clinical characteristics; Tools of diagnosis; Referral of suspected HCM to a cardiologist.

  • Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C. Brown, Louise J.; Singh, Leena; Sale, Kenneth L.; Yu, Bing; Trent, Ronald; Fajer, Peter G.; Hambly, Brett D. // European Biophysics Journal;2002, Vol. 31 Issue 5, p400 

    Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disorder caused by mutations in cardiac sarcomeric proteins. One such mutation is a six amino acid duplication of residues 1248–1253 in the C-terminal immunoglobulin domain of cardiac myosin binding protein-C, referred...

  • Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac β-myosin gene mutations Havndrup, Ole; Bundgaard, Henning; Skytt Andersen, Paal; Allan Larsen, Lars; Vuust, Jens; Kjeldsen, Keld; Christiansen, Michael // Cardiovascular Research;Feb2003, Vol. 57 Issue 2, p347 

    Objective: Familial hypertrophic cardiomyopathy (FHC) is caused by mutations in genes encoding cardiac sarcomere proteins. Although available, genetic analyses are generally not used clinically. In the present study, we evaluated the outcome of clinical vs. genetic screening of family...

  • 205 Septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: an analysis of the patients with persisting NYHA class III symptoms during long-term follow-up. Faber, L.; Welge, D.; Seggewiss, H.; Fassbender, D.; Horstkotte, D. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p42 

    An abstract of the article "Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: An Analysis of the Patients With Persisting NYHA Class III Symptoms During Long-Term Follow-Up," by L. Faber and colleagues is presented.

  • Impact of α-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol Takahashi, Ryotaro; Okumura, Kenji; Matsui, Hideo; Saburi, Yoshihiro; Kamiya, Hiroki; Matsubara, Kenichiro; Asai, Toru; Ito, Masafumi; Murohara, Toyoaki // Cardiovascular Research;Jun2003, Vol. 58 Issue 3, p565 

    Objective: The juvenile visceral steatosis (JVS) mouse, a murine model of systemic carnitine deficiency, shows a disorder of fatty acid oxidation and develops cardiac hypertrophy associated with lipid accumulation. Recently, α-tocopherol was shown to decrease 1,2-diacylglycerol (DAG)...

  • Myocardial texture in hypertrophic remodelling: new insight into ventricular load and function? St John Sutton, M; Plappert, T // Journal of Human Hypertension;Jan2000, Vol. 14 Issue 1, p7 

    Comments on the significance of myocardial texture in the stimulation of hypertrophy and ventricular remodelling. Relationship between left ventricular cavity size and wall thickness; Phases into which left ventricular hypertrophy has been divided; Impact of hypertrophy on left ventricular...

  • Myocardial disarray revisited. Olsen, E.G.J. // British Medical Journal (Clinical Research Edition);10/9/1982, Vol. 285 Issue 6347, p991 

    Examines the irregular arrangement of myocardial fibers within the myocardium. Use of myocardial fibers as morphological markers for hypertrophic cardiomyopathy; Evaluation of various cardiac condition using the myocardial fibers; Morphological diagnosis of hypertrophic cardiomyopathy.

  • Epidemiology and genetics of hypertrophic cardiomyopathy. Tanjore, Reena R.; Thakkar, Bhavesh; Sikindlapuram, Annapurna D.; Narasimhan, Calambur; Kerkar, Prafulla G.; Vajjha, Haragopal V.; Nallari, Pratibha // Indian Journal of Human Genetics;Jan-Apr2006, Vol. 12 Issue 1, p26 

    BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a heart muscle disorder and is known to be inherited as an autosomal dominant trait. Mutations in several sarcomeric, cytoskeletal and mitochondrial genes have been reported in HCM. Though many cases of HCM are being identified, there is limited...

  • Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. Weiguang Zhong; Songyan Mao; Tobis, Scott; Angelis, Ekaterini; Jordan, Maria C.; Roos, Kenneth P.; Fishbein, Michael C.; de Alborán, Ignacio Moreno; MacLellan, W Robb // EMBO Journal;8/23/2006, Vol. 25 Issue 16, p3869 

    c-Myc (Myc) is highly expressed in developing embryos where it regulates body size by controlling proliferation but not cell size. However, Myc is also induced in many postmitotic tissues, including adult myocardium, in response to stress where the predominant form of growth is an increase in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics